| Composition | Rosuvastatin 10mg Aspirin 75mg |
|---|---|
| Dosage | CAPSULE |
| Packing Size | 10×10 |
| Packing | Strip |
ROZVIN AS 10/75 is a dual-action cardiovascular medication that combines Rosuvastatin 10 mg, a lipid-lowering statin, with Aspirin 75 mg, a low-dose antiplatelet agent. This combination is formulated to manage cholesterol levels while reducing the risk of blood clot formation, helping prevent heart attack, stroke, and other cardiovascular events in at-risk patients.
By targeting two major cardiovascular risk factors—high cholesterol and platelet aggregation, ROZVIN AS 10/75 provides comprehensive heart protection in a single convenient tablet.
Each tablet contains:
Rosuvastatin 10 mg – HMG-CoA reductase inhibitor that lowers LDL cholesterol, total cholesterol, and triglycerides while increasing HDL cholesterol.
Aspirin 75 mg – Antiplatelet agent that prevents platelet aggregation, reducing the risk of thrombotic cardiovascular events.
(Excipients q.s., as per approved formulation.)
Tablet
Lipid-Lowering & Antiplatelet Therapy / Cardiovascular Protection
ROZVIN AS 10/75 Tablets are indicated for:
Patients with hypercholesterolemia and high cardiovascular risk
Prevention of heart attack, stroke, or other thrombotic events
Secondary prevention in patients with previous myocardial infarction or coronary artery disease
Patients requiring cholesterol management combined with antiplatelet therapy
Rosuvastatin inhibits the HMG-CoA reductase enzyme, reducing cholesterol synthesis in the liver and improving the lipid profile.
Aspirin irreversibly inhibits platelet aggregation, preventing thrombus formation and lowering the risk of cardiovascular events.
The combination addresses cholesterol management and blood clot prevention simultaneously, providing effective cardiovascular protection.
Recommended Dose: As prescribed by the physician, usually once daily
Route: Oral
Duration: Long-term therapy as advised by a healthcare provider
Note: Regular monitoring of lipid profile, liver function, and bleeding risk is recommended during therapy.
Lowers LDL cholesterol and triglycerides
Increases HDL cholesterol
Prevents platelet aggregation and blood clots
Reduces risk of heart attack, stroke, and atherosclerosis
Convenient once-daily tablet improves patient compliance
ROZVIN AS 10/75 is generally well tolerated. Possible side effects include:
Mild gastrointestinal disturbances (nausea, abdominal discomfort)
Headache or dizziness
Muscle pain or weakness (rare, associated with statins)
Increased risk of bleeding due to Aspirin
Patients should consult their physician if side effects persist or worsen.
Avoid in patients with active bleeding disorders or history of hemorrhagic stroke
Use with caution in liver or kidney impairment
Not recommended during pregnancy or lactation
Inform your doctor about other medications to prevent interactions
Regular monitoring of liver enzymes, lipid profile, and bleeding risk is advised
Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.
Brand Name: ROZVIN AS 10/75
Composition: Rosuvastatin 10 mg + Aspirin 75 mg
Dosage Form: Tablet
Therapeutic Class: Lipid-Lowering & Antiplatelet / Cardiovascular Protection
Manufacturer: [Insert Company Name]
Packaging: [Example: 10×10 Tablets / Strip]
Combines cholesterol management and antiplatelet therapy in a single tablet
Helps reduce cardiovascular risk in high-risk patients
Convenient once-daily dosing improves compliance
Manufactured under strict GMP-certified quality standards
ROZVIN AS 10/75 (Rosuvastatin 10 mg + Aspirin 75 mg Tablets) provides dual cardiovascular protection by managing cholesterol levels and preventing blood clots. This comprehensive therapy reduces the risk of heart attack, stroke, and atherosclerosis, supporting long-term heart health and overall cardiovascular wellness.
